Halozyme To Report Third Quarter 2023 Financial and Operating Results

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2023 financial and operating results...

Related Keywords

San Diego ,California ,United States ,Eli Lilly ,Teva Pharmaceuticals ,Twitter ,Prnewswire Halozyme Therapeutics Inc ,Pfizer ,Linkedin ,Halozyme Therapeutics Inc ,Bristol Myers Squibb ,Corporate Communications ,Nasdaq ,Idorsia Pharmaceuticals ,Horizon Therapeutics ,Viiv Healthcare ,Investor Relations ,Halozyme Therapeutics ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Conference Call Announcements ,